ArticleProceedings (Baylor University. Medical Center)2026
National mortality trends in mood affective disorders and hypertensive/ischemic heart diseases in the United States, 1999 to 2020: a CDC WONDER analysis.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study assessed demographic and geographic trends in mortality linked to mood affective disorders (MAD) and hypertensive/ischemic heart diseases (HHD/IHD) in the United States. Methods: Death certificate data from CDC WONDER (1999-2020) were analyzed to identify individuals (≥15 years) with MAD and HHD/IHD listed as underlying or contributing causes of death. Age-adjusted mortality rates (AAMRs) per 100,000 and annual percent change (APC) were calculated by year, sex, race/ethnicity, and region. Results: From 1999 to 2020, 198,332 MAD-HHD/IHD-related deaths were recorded. The overall AAMR rose from 2.53 in 1999 to 5.05 in 2020. Women had consistently higher AAMRs than men (2.65 vs 2.30 in 1999; 5.36 vs 4.53 in 2020). Non-Hispanic Whites had the highest AAMR (3.57), followed by American Indian/Alaska Natives (2.31). North Dakota (7.51) and the Midwest (4.45) recorded the highest regional rates. Nonmetropolitan areas (6.73) showed higher mortality than metropolitan ones (3.29). Conclusion: MAD-HHD/IHD mortality has steadily increased, with notable sex, racial, and geographic disparities, highlighting the need for targeted preventive strategies, such as improved mental health screening, cardiovascular risk assessment, and integrated care, as well as policy measures aimed at expanding access to mental health and cardiovascular services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.